NCT04403555View on ClinicalTrials.gov

Ivermectin as a Novel Therapy in COVID-19 Treatment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

October 31, 2020

Study Completion Date

December 1, 2020

Conditions
COVID
Interventions
DRUG

Ivermectin

Ivermectin treatment

Trial Locations (1)

Unknown

Sherief Abd-Elsalam, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT04403555 - Ivermectin as a Novel Therapy in COVID-19 Treatment | Biotech Hunter | Biotech Hunter